Evidence map›Paper›PMID 41752125›Full record

ArticleInternational journal of molecular sciences2026

AI-Guided Binding Mechanisms and Molecular Dynamics for MERS-CoV.

Pradyumna Kumar, Lingtao Chen, Rachel Yuanbao Chen, Yin Chen, Seyedamin Pouriyeh, Progyateg Chakma, Abdur Rahman Mohd Abul Basher, Yixin Xie

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pradyumna KumarCollege of Computing and Software Engineering, Kennesaw State University, Marietta, GA 30060, USA.ORCID 0009-0003-7643-9829
Lingtao ChenCollege of Computing and Software Engineering, Kennesaw State University, Marietta, GA 30060, USA.ORCID 0000-0002-8345-2250
Rachel Yuanbao ChenDepartment of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Yin ChenDepartment of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Seyedamin PouriyehCollege of Computing and Software Engineering, Kennesaw State University, Marietta, GA 30060, USA.ORCID 0000-0002-5746-2914
Progyateg ChakmaDepartment of Chemistry and Biochemistry, Kennesaw State University, Kennesaw, GA 30144, USA.
Abdur Rahman Mohd Abul BasherCollege of Computing and Software Engineering, Kennesaw State University, Marietta, GA 30060, USA.ORCID 0000-0002-3407-1187
Yixin XieCollege of Computing and Software Engineering, Kennesaw State University, Marietta, GA 30060, USA.ORCID 0000-0002-4436-3474

Funding

Kennesaw State University Research Seed Fund, Arizona Biomedical Research Commission (ABRC) Investigator Award RFGA2024-022 AZ IG
6 · The paper itself

Abstract

The MERS-CoV (Middle East respiratory syndrome coronavirus) is a zoonotic virus with a high mortality rate and a lack of antiviral drugs, underscoring the need for effective therapeutic methods. Viral entry depends on interactions between viral surface proteins and human receptors, with Dipeptidyl Peptidase-4 (DPP4), a transmembrane glycoprotein, acting as the receptor for MERS-CoV. We employed Molecular Dynamics (MD) Simulations to identify critical interface residues under a high-performance computing (HPC) workflow for accelerated results. Target residue pairs were identified through analysis of salt bridge and hydrogen bond occupancy. The stability of these residues was confirmed through three independent MD Simulations at human body temperature and constant pressure. Additionally, binding affinity predictions were calculated to determine the interaction strength between the virus and human receptors. Applying the scientific threshold criteria, we narrowed our results to seven key interaction pairs; two of the identified pairs (Asp510-Arg317, and Arg511-Asp393) are consistent with findings published in previous research studies, and five novel interactions are proposed for future experimental studies with our active collaborators in Pharmacology. The results provide a molecular basis for targeted mutation-based experiments and support the rational design of structure-based inhibitors aimed at disrupting the MERS-CoV-DPP4 complex, thereby facilitating the translation of computational findings into antiviral drug discovery.

Indexed as

Dipeptidyl Peptidase 4Middle East Respiratory Syndrome CoronavirusMolecular Dynamics SimulationCoronavirus InfectionsHumansHydrogen BondingIntelligent SystemsProtein BindingDipeptidyl Peptidase 4Artificial Intelligence (AI)binding affinitycoronavirusdrug targethigh performance computing (HPC)hydrogen bondsMERS-CoVmolecular simulationsprotein–protein interaction (PPI)salt bridge analysis

Identifiers

PMID41752125
PMCPMC12940564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.